Resources

Past Presentation

Histoplasmosis | August 17 2023

Date of Presentation: August 17, 2023

Type: Past Presentation  

Audience: Clinical  

Program: Infectious Disease ECHO Program  

Keywords: #covid-19  #Histoplasmosis  #infectious disease  #pneumonia  #respiratory illness  

In this series of presentations, Dr. Jonathan Iralu, Chief Clinical Consultant for Infectious Diseases at IHS, presents on Emerging Infectious Disease updates followed by Dr. Marisa Miceli on the microbiology, epidemiology, risk factors, clinical presentation, and treatment of Histoplasmosis. Histoplasmosis is an invasive fungal infection that often presents as pneumonia and is the most prevalent endemic mycosis in US. It affects both immunocompetent and immunocompromised persons and often cannot be distinguished from other causes of respiratory illness based on clinical presentation alone.

Recording:

Presented by:

Dr. Jonathan Iralu and Dr. Marisa H. Miceli

Dr. Jonathan Iralu, MD, FACP, FISDA, is the Indian Health Service Chief Clinical Consultant for Infectious Diseases. He has a special interest in HIV, tuberculosis, and sexually transmitted disease care in rural communities. His research has focused on undifferentiated febrile illness in the American Southwest and on rural HIV care delivery. He has worked at Gallup Indian Medical Center since 1994 and is an instructor at Harvard Medical School and Senior Physician at Brigham and Women’s Hospital Division of Global Health Equity in Boston, Massachusetts.

Dr. Marisa Miceli is an Associate Professor in the Division of Infectious Diseases at the University of Michigan Medical School. She specializes in Medical Mycology and Transplant Infectious Diseases. Dr. Miceli is active in both direct patient care and clinical research. Her scholarly work focuses on addressing unmet needs in the diagnosis of invasive fungal infections and in the treatment of patients with these diseases. Dr. Miceli is the Principal Investigator for several Phase 2 and 3 clinical trials for the study of novel antifungal agents. Dr. Miceli teaches and mentors Infectious Diseases Fellows and Internal Medicine Residents in the field of transplant Infectious diseases and medical mycology. Dr Miceli has published more than 80 manuscripts in peer-reviewed journals, including Clinical Infectious Diseases, The Lancet Infectious Diseases, Infectious Disease Clinics of North America, Mycoses, and Transplant Infectious Diseases. She also has published 8 book chapters. She reviews for more than 15 journals and is an Editorial Board Member for Mycopathologia and Journal of Fungi. Dr. Miceli serves as Treasurer in the Board of Directors of the Mycoses Study Group Education and Research Consortium; she is a Fellow of the American College of Physicians and the Infectious Diseases Society of America.

Resources Provided:

Date added: August 17, 2023